Non-Insulin Therapies for Diabetes Market Data Survey Report 2013-2025
Summary
The Non-Insulin Therapies for Diabetes market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
market size by Major Application
market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
GSK
Eli Lilly
Sumitomo Dainippon Pharma
Intarcia Therapeutics
Servier
Jiangsu Hansoh Pharmaceutical
Novo Nordisk
Emisphere
Uni-Bio Science Group
Takeda
3SBio
Merck
Dong-A Pharmaceutical
Luye Pharma Group
Eurofarma
Geropharm
Alkem Labs
SatRx
Pfizer
Jiangsu Hengrui Medicine
Major applications as follows:
Hospital Pharmacy
Retail Pharmacies
Online Pharmacy
Others
Major Type as follows:
Alpha-glucosidase Inhibitors
Amylin Agonists
Biguanides
Dipeptidyl Peptidase-4 (DPP4) Inhibitors
Glinides / Meglitinides
GLP-1 Analogs / GLP-1 Agonists
Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
Sulfonylureas
Thiazolidinediones
Others
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Type
1.1.5 Scope of Regions/Countries
1.2 Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 GSK
3.1.1 Company Information
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.1.4 Recent Development
3.2 Eli Lilly
3.2.1 Company Information
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2.4 Recent Development
3.3 Sumitomo Dainippon Pharma
3.3.1 Company Information
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3.4 Recent Development
3.4 Intarcia Therapeutics
3.4.1 Company Information
3.4.2 Product & Services
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4.4 Recent Development
3.5 Servier
3.5.1 Company Information
3.5.2 Product & Services
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5.4 Recent Development
3.6 Jiangsu Hansoh Pharmaceutical
3.6.1 Company Information
3.6.2 Product & Services
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6.4 Recent Development
3.7 Novo Nordisk
3.7.1 Company Information
3.7.2 Product & Services
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7.4 Recent Development
3.8 Emisphere
3.8.1 Company Information
3.8.2 Product & Services
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8.4 Recent Development
3.9 Uni-Bio Science Group
3.9.1 Company Information
3.9.2 Product & Services
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9.4 Recent Development
3.10 Takeda
3.10.1 Company Information
3.10.2 Product & Services
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10.4 Recent Development
3.11 3SBio
3.11.1 Company Information
3.11.2 Product & Services
3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11.4 Recent Development
3.12 Merck
3.12.1 Company Information
3.12.2 Product & Services
3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.12.4 Recent Development
3.13 Dong-A Pharmaceutical
3.13.1 Company Information
3.13.2 Product & Services
3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.13.4 Recent Development
3.14 Luye Pharma Group
3.14.1 Company Information
3.14.2 Product & Services
3.14.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.14.4 Recent Development
3.15 Eurofarma
3.15.1 Company Information
3.15.2 Product & Services
3.15.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.15.4 Recent Development
3.16 Geropharm
3.16.1 Company Information
3.16.2 Product & Services
3.16.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.16.4 Recent Development
3.17 Alkem Labs
3.17.1 Company Information
3.17.2 Product & Services
3.17.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.17.4 Recent Development
3.18 SatRx
3.18.1 Company Information
3.18.2 Product & Services
3.18.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.18.4 Recent Development
3.19 Pfizer
3.19.1 Company Information
3.19.2 Product & Services
3.19.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.20 Jiangsu Hengrui Medicine
3.20.1 Company Information
3.20.2 Product & Services
3.20.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
4.1 Hospital Pharmacy
4.1.1 Overview
4.1.2 Hospital Pharmacy Market Size and Forecast
4.2 Retail Pharmacies
4.2.1 Overview
4.2.2 Retail Pharmacies Market Size and Forecast
4.3 Online Pharmacy
4.3.1 Overview
4.3.2 Online Pharmacy Market Size and Forecast
4.4 Others
4.4.1 Overview
4.4.2 Others Market Size and Forecast
5 Market by Type
5.By Alpha-glucosidase Inhibitors
5.1 Alpha-glucosidase Inhibitors
5.1.1 Overview
5.1.2 Alpha-glucosidase Inhibitors Market Size and Forecast
5.2 Amylin Agonists
5.2.1 Overview
5.2.2 Amylin Agonists Market Size and Forecast
5.3 Biguanides
5.3.1 Overview
5.3.2 Biguanides Market Size and Forecast
5.4 Dipeptidyl Peptidase-4 (DPP4) Inhibitors
5.4.1 Overview
5.4.2 Dipeptidyl Peptidase-4 (DPP4) Inhibitors Market Size and Forecast
5.5 Glinides / Meglitinides
5.5.1 Overview
5.5.2 Glinides / Meglitinides Market Size and Forecast
5.6 GLP-1 Analogs / GLP-1 Agonists
5.6.1 Overview
5.6.2 GLP-1 Analogs / GLP-1 Agonists Market Size and Forecast
5.7 Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
5.7.1 Overview
5.7.2 Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Market Size and Forecast
5.8 Sulfonylureas
5.8.1 Overview
5.8.2 Sulfonylureas Market Size and Forecast
5.9 Thiazolidinediones
5.9.1 Overview
5.9.2 Thiazolidinediones Market Size and Forecast
5.10 Others
5.10.1 Overview
5.10.2 Others Market Size and Forecast
6 Price Overview
6.1 Price by Manufacturers
6.2 Price by Application
6.3 Price by Type
7 Conclusion